Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Assembly Biosciences (ASMB) over the last 16 years, with Dec 2024 value amounting to $3.1 million.

  • Assembly Biosciences' Share-based Compensation rose 109.54% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 19.20%. This contributed to the annual value of $3.1 million for FY2024, which is 39.05% down from last year.
  • According to the latest figures from FY2024, Assembly Biosciences' Share-based Compensation is $3.1 million, which was down 39.05% from $5.1 million recorded in FY2023.
  • In the past 5 years, Assembly Biosciences' Share-based Compensation ranged from a high of $21.9 million in FY2020 and a low of $3.1 million during FY2024.
  • Over the past 3 years, Assembly Biosciences' median Share-based Compensation value was $5.1 million (recorded in 2023), while the average stood at $4.9 million.
  • As far as peak fluctuations go, Assembly Biosciences' Share-based Compensation slumped by 76.04% in 2021, and later rose by 25.89% in 2022.
  • Yearly analysis of 5 years shows Assembly Biosciences' Share-based Compensation stood at $21.9 million in 2020, then plummeted by 76.04% to $5.2 million in 2021, then increased by 25.89% to $6.6 million in 2022, then declined by 22.36% to $5.1 million in 2023, then crashed by 39.05% to $3.1 million in 2024.